VIFN Stock Price, News & Analysis

VIFN

Company Description

VIFN (NYSE: VIFN) is a publicly traded company.

This page provides a comprehensive overview of VIFN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

March 8, 2021

—

Vifor Pharma and Cara Therapeutics announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus

clinical trial fda approval

VIFN has 1 recent news article. Key topics include clinical trial, fda approval. View all VIFN news →

SEC Filings

View All

No SEC filings available for VIFN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months